Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: An observational cohort study of 43 cases from an international multicentre registry

BMJ Open

Volumn 3, Issue 3, 2013, Pages

  Tiller, Heidi ^a   Kamphuis, Marije M ^b   Flodmark, Olof ^c   Papadogiannakis, Nikos ^d   David, Anna L ^e   Sainio, Susanna ^f   Koskinen, Sinikka ^f   Javela, Kaija ^f   Wikman, Agneta Taune ^c   Kekomaki, Riitta ^f   Kanhai, Humphrey H H ^b   Oepkes, Dick ^b   Husebekk, Anne ^g   Westgren, Magnus ^h  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Section of Perinatal Pathology   (Sweden)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f FINNISH RED CROSS BLOOD SERVICE   (Finland)

^g UNIVERSITY OF TROMSØ   (Norway)

^h Division of Clinical Immunology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CESAREAN SECTION; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DELIVERY; FEMALE; FETUS; FETUS DEATH; FETUS ECHOGRAPHY; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LABOR; MALE; MATERNAL AGE; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEUROLOGIC DISEASE; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL CARE; PRIMIGRAVIDA; SECOND TRIMESTER ABORTION; SECOND TRIMESTER PREGNANCY; STEROID THERAPY; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; VAGINAL DELIVERY;

EID: 84876155932     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002490     Document Type: Article

References (18)

1. Mao C, Guo J, Chituwo BM. Intraventricular haemorrhage and its prognosis, prevention and treatment in term infants. J Trop Pediatr 1999;45:237-40. (Pubitemid 29385260)
2. Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280-7. (Pubitemid 28452968)
3. Kamphuis MM, Paridaans N, Porcelijn L, et al. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. BJOG 2010;117:1335-43.
4. Jocelyn LJ, Casiro OG. Neurodevelopmental outcome of term infants with intraventricular hemorrhage. Am J Dis Child 1992;146:194-7.
5. Radder CM, Brand A, Kanhai HH. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang 2003;84:318-25. (Pubitemid 36702338)
6. Kamphuis MM, Oepkes D. Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenat Diagn 2011;31:712-19.
7. Kanhai HH, Porcelijn L, Engelfriet CP, et al. Management of alloimmune thrombocytopenia. Vox Sang 2007;93:370-85. (Pubitemid 350135084)
8. Pacheco LD, Berkowitz RL, Moise KJ, et al. Fetal and neonatal alloimmune thrombocytopenia. A management algorithm based on risk stratification. Obstet Gynecol 2012;118:1157-63.
9. Osborn AG. Imaging of intracranial hemorrhage. Diagnostic neuroradiology. St Louis: Mosby, 1994:158-73.
10. Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy. JAMA 2012;296:1602-8.
11. Kiefel V, Santoso S, Weisheit M, et al. Monoclonal antibody - specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-6. (Pubitemid 18055614)
12. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-55. (Pubitemid 32201293)
13. Bussel JB, Berkowitz RL, Hung C, et al. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol 2010;203:135-14.
14. Tiller H, Killie MK, Skogen B, et al. Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys. Acta Obstet Gynecol Scand 2011;91:79-86.
15. Kjeldsen-Kragh J, Killie MK, Tomter G, et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007;110:833-9. (Pubitemid 47267418)
16. Kjeldsen-Kragh J, Ni H, Skogen B. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia. Curr Opin Hematol 2012;19:469-74.
17. Tiller H, Killie MK, Chen P, et al. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Transfusion 2012;52:1446-57.
18. van den AE, Oepkes D, Brand A, et al. Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia? BJOG 2006;113:781-3 (Pubitemid 43961738)